Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 AlteredExpression disease BEFREE Secretory leukocyte protease inhibitor (SLPI) is overexpressed in gastric, lung and ovarian cancers, which accelerates the metastasis of cancer cells. 28429358 2017
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 Biomarker disease BEFREE These findings further support SLPI as a molecular target for ovarian cancer. 21676452 2011
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 AlteredExpression disease BEFREE SLPI is also overexpressed in gastric, lung and ovarian cancers, which accelerates the metastasis of cancer cells. 21687932 2011
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 Biomarker disease BEFREE We showed that secretory leukocyte protease inhibitor (SLPI) is a survival factor for ovarian cancer. 20068074 2010
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 Biomarker disease BEFREE SLPI protected the ovarian cancer survival factor, progranulin (PRGN), and HEY-A8 cells from degradation and apoptosis due to neutrophil elastase. 19154415 2009
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 Biomarker disease BEFREE These data demonstrate that inappropriate over-expression of the alarm anti-protease, SLPI, creates a pro-survival milieu for ovarian cancer. 17916899 2008
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 AlteredExpression disease BEFREE Viruses containing the SLPI or the ubiquitously expressed CMV promoter, with or without sCARfC6.5, were used for infection of ovarian cancer cell lines, primary ovarian tumor cells, and in an orthotopic model of disseminated ovarian carcinoma. 12833129 2003
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.080 Biomarker disease BEFREE We hypothesize that selective adenovirus-mediated transgene expression could be achieved through the use of the secretory leukoprotease inhibitor (SLPI) promoter in the context of ovarian cancer. 12692864 2003